At SEEDSUPPLY, we are dedicated to reshaping the future of drug discovery.
Our name reflects our mission: to supply the seeds—the essential starting points—for groundbreaking therapeutics. These seeds are the binding compounds and target proteins that form the foundation of innovative drug discovery.
By harnessing our proprietary technologies—including advanced Affinity Selection Mass Spectrometry (ASMS)—we enable the direct identification of hit compounds and target proteins, even for challenging membrane proteins such as SLC transporters and GPCRs.
Our unique approach focuses on what truly matters: unlocking novel, first-in-class therapeutics by accessing targets and ligands often overlooked by conventional methods.
Through comprehensive screening of 400,000 compounds and 17,000 proteins under native conditions, we accelerate the discovery of innovative treatments that open new therapeutic possibilities.
SEEDSUPPLY empowers researchers and pharmaceutical innovators worldwide—bridging the gap between untapped biological insights and real-world therapies.

From conventional stepwise discovery to an integrated, accelerated pathway.
By starting with our Binder Collection—pre-validated compounds that already bind potential targets—SEEDSUPPLY shifts the focus from target-first to binder-driven discovery.
This paradigm shift allows target research and lead generation to advance simultaneously, dramatically shortening timelines and reducing risk.
Traditional discovery waits. SEEDSUPPLY grows innovation from day one.

SEEDSUPPLY INC. will present a poster at the Bio-IT World Conference & Expo 2026, to be held in Boston, USA, from May 19–21, 2026.
Poster Title:
Binder2030: Standardized Binding Data to Benchmark and Calibrate AI Models for Membrane Protein Drug Discovery
The presentation will introduce Binder2030, SEEDSUPPLY’s standardized membrane protein binding dataset designed to support AI-driven drug discovery through experimental ground truth generation and affinity prediction benchmarking.
The poster will highlight standardized native-state binding measurements across membrane protein classes and their application to AI model benchmarking and calibration.
Event: Bio-IT World Conference & Expo 2026
Date: May 19–21, 2026
Location: Boston, Massachusetts, USA